Gene · 9780
Papers3,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microenvironment-mediated stem cell fate in periodontal tissue remodeling and repair. | Bioact Mater | 2026 | 41541277 | PubTator, text mining | PubMed |
| Emerging S100A11 roles: Regulation of focal adhesion dynamics and mechanosensing. | Cell Struct Funct | 2026 | 41535022 | PubTator, text mining | PubMed |
| Piezo1 dictates K+ homeostasis through coordinated regulation of the ubiquitin ligase Kelch-like 3 in RBCs and the kidney. | Proc Natl Acad Sci U S A | 2026 | 41533447 | PubTator, text mining | PubMed |
| Anisotropic mechanotransductive tissue constructs via brush-assisted bioprinting of microfiber-reinforced composite bioinks. | Bioact Mater | 2026 | 41532008 | PubTator, text mining | PubMed |
| Mechanoresponsive ion channels Piezo1 and TRPV4 stimulate ADAM10 and ADAM17 with differential impact on endothelial migration and proliferation. | Cell Commun Signal | 2026 | 41519760 | PubTator, text mining | PubMed |
| Physical stimuli-responsive CRISPR-Cas9 systems for spatiotemporally precise control of genome engineering. | Theranostics | 2026 | 41510162 | PubTator, text mining | PubMed |
| Piezo1-mediated autophagy promotes immune-inflammatory responses in ankylosing spondylitis. | Cell Death Dis | 2026 | 41507149 | PubTator, text mining | PubMed |
| Mechanistic Consequences of Piezo1 Gain-of-Function Variants for Decreased Red Cell Survival in Hereditary Xerocytosis. | Am J Hematol | 2026 | 41504168 | PubTator, text mining | PubMed |
| Nuclear mechanobiology rules immune cells' functions: from differentiation to cell trafficking and pathogen killing. | Nucleus | 2026 | 41495604 | PubTator, text mining | PubMed |
| Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt signaling. | Mater Today Bio | 2026 | 41476751 | PubTator, text mining | PubMed |
| PIEZO1 channel mechanosensing in hepatobiliary physiology and disease. | Am J Physiol Cell Physiol | 2026 | 41467771 | PubTator, text mining | PubMed |
| Traceless Regulation of Genetic Circuitry. | Adv Sci (Weinh) | 2026 | 41454732 | PubTator, text mining | PubMed |
| Piezo1 as a therapeutic target in kidney disease: emerging mechanistic insights and translational potential. | Drug Discov Today | 2026 | 41448346 | PubTator, text mining | PubMed |
| Piezo-type mechanosensitive ion channel component 1: a mechano-bioenergetic transducer in the tumour microenvironment. | Ann Med | 2026 | 41437911 | PubTator, text mining | PubMed |
| Osteoarthritis year in review 2025: Biology. | Osteoarthritis Cartilage | 2026 | 41418993 | PubTator, text mining | PubMed |
| The mechanosensitive Piezo channels as potential therapeutic targets for osteoarthritis. | Biochem Pharmacol | 2026 | 41407166 | PubTator, text mining | PubMed |
| PIEZO mechanosensitivity in chondrocytes is differentially modulated by L-type and T-type voltage-sensitive ion channels. | Osteoarthr Cartil Open | 2026 | 41399468 | PubTator, text mining | PubMed |
| Genome-wide association studies in chronic venous disease: A systematic review. | J Vasc Surg Venous Lymphat Disord | 2026 | 41391741 | PubTator, text mining | PubMed |
| Piezo1-mediated neuroexcitation via collaboration with KCa1.1 and Nav1.9 currents in myelinated Ah-type of trigeminal ganglion neurons in rats: Mechanistic insights with sex-specific effects. | Mol Pain | 2026 | 41384612 | PubTator, text mining | PubMed |
| High-fat diet induced ECM remodeling attenuates chemosensitivity in prostate cancer via activating Piezo1-dependent mitochondria-ER contacts. | Cancer Lett | 2026 | 41380904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9780/papers?page=21